These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 7910810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G, Schirmböck M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G.
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG.
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [Abstract] [Full Text] [Related]

  • 6. Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells.
    Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, Wilmanns C, Fidler IJ.
    J Natl Cancer Inst; 1994 Jun 15; 86(12):913-20. PubMed ID: 7910854
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multidrug resistance in rat colon carcinoma cell lines CC531, CC531mdr+ and CC531rev.
    Gheuens E, van der Heyden S, Elst H, Eggermont A, Van Oosterom A, De Bruijn E.
    Jpn J Cancer Res; 1993 Nov 15; 84(11):1201-8. PubMed ID: 7903965
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.
    Isaacs JT, Isaacs WB, Feitz WF, Scheres J.
    Prostate; 1986 Nov 15; 9(3):261-81. PubMed ID: 3774632
    [Abstract] [Full Text] [Related]

  • 13. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U, Walther W, Shoemaker RH.
    J Natl Cancer Inst; 1996 Oct 02; 88(19):1383-92. PubMed ID: 8827016
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.
    Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D, Huryk R.
    Cancer Res; 1996 Sep 15; 56(18):4137-41. PubMed ID: 8797581
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
    Schott B, Bennis S, Pourquier P, Ries C, Londos-Gagliardi D, Robert J.
    Int J Cancer; 1993 Aug 19; 55(1):115-21. PubMed ID: 8102127
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
    Evans CH, Baker PD.
    Cancer Res; 1992 Nov 01; 52(21):5893-9. PubMed ID: 1356622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.